We look forward to sharing our latest gene editing data using LentiFlashTM with you, an innovative RNA delivery particle. This cutting-edge technology is a safe and efficient opportunity to deliver CRISPR/Cas9 system for gene and cell therapy applications.
"Efficient KO of PD1 into primary T cells using a new non-integrative lentiviral particle expressing CRISPR/Cas9 system."
Poster session details:
Session Date/Time: Thursday, May 11, 5:15 PM - 7:15 PM
Session title: RNA Virus Vectors
Room: Exhibit hall A and B South
Abstract number: 458
Our staff on site :
Pascale Bouille, CEO of Vectalys and Regis Gayon, Vectorology and Cell Models Manager.
If you would like to set up an appointment prior to the annual meeting, please contact us at email@example.com or by phone +33 5 82 99 11 02.
We are looking forward to seeing you there!
The Vectalys Team